In the main analysis, we investigated what clinical and sociodemographic factors affected WCST factor scores in a multiple logistic regression analysis.
The main analysis will investigate differences in the DRI score at 1 year after injury, between the two treatment groups on an intention-to-treat basis.
The main analysis will investigate differences in DRI 6 months postsurgery, between the two treatment groups, on an intention-to-treat basis.
The main analysis will investigate differences in the primary outcome measure, the DRI score at 1 year after injury, between the two treatment groups (standard wound dressings and negative pressure wound therapy) on an intention-to-treat basis.
The main analysis will investigate differences in the primary outcome measure, cartilage volume between the treatment groups (operative and non-operative) on an intention-to-treat basis, at 12 months post-intervention.
The main analysis will investigate differences in the primary outcome measures, the Harris Hip Score and the patient-reported Oxford Hip Score, between the two treatment groups on an intention-to-treat basis.
The main analysis will investigate differences in the primary outcome measure, the DRI at 6 months after surgery, between the two treatment groups on an intention-to-treat basis.
The main analysis for investigating the association between MTHFR 677TT and risk of developing T2DM relative to the 677CC revealed significant heterogeneity (p for heterogeneity = 0.035, I = 43%) between 17 studies; the random effect (RE) pooled OR was significant: RE OR = 1.33 (1.05-1.67) (p = 0.021).
The main analysis will investigate differences in the primary outcome measure, the VAS pain score prephysiotherapy on the first day postoperatively, between the two treatment groups (single injection femoral nerve block and multimodal periarticular injection) on an intention-to-treat basis.
